Skip to content
Research Article Open access CC BY 4.0

Digoxin Inhibits Retinoblastoma through Suppressing a Non-canonical TGFβ Signaling Pathway

Maryam Sheikhzade, Abolfazl Akbari, Reza Karkhaneh, Fariba Ghassemi, Abdolrahim Sadeghi, Mahshid Shahrzad Kavakani, Gholam Reza Mobini, Masoumeh Mohebbi, Mansour Heidari

Journal of Advances in Medicine and Medical Research · pp. 1–10 · Published 28 Apr 2016

10.9734/BJMMR/2016/25709

Abstract

Aims: Retinoblastoma is a childhood ocular tumor rapidly developing from the immature cells of the retina due to loss of functional retinoblastoma protein. Digoxin, a cardiac glycoside, has been reported to be effective in inducing apoptosis, cell cycle arrest, and cytotoxic effects on human cancers. In this regard, the present study aims to investigate whether digoxin could suppress retinoblastoma cancer through the regulation of transforming growth factor-β (TGF-β) signaling pathway. Methodology: The effects of digoxin on Y-79 cells, retinoblastoma cancer cell line, were investigated using MTT (3-(4,5-dimethylthiazole-2-yl)-2,5-diphenyltetrazoli-umbromide) and BrdU (bromodeoxyuridine) assays to measure cellular cytotoxicity effects and cell apoptosis, respectively. Also, a qPCR assay was employed to analyze the mRNA expression levels of TGFβ signaling pathway including C-MYC, P21, P15, TGFβRI, TGFβRII, and SMAD2, 3, and 4 genes. Results: The results of the cell function assays revealed that digoxin inhibited the cell viability and proliferation of Y-79 cells. In addition, it was found that digoxin significantly suppressed C-MYC expression and enhanced the expression of P21, P15, SMAD2 and SMAD4 genes in a dose-and time-dependent manner. However, the obtained results could not detect any significant effect of digoxin on TGFβRI, TGFβRII and SMAD3 genes. Conclusion: Taken together, the findings of the present study suggest that digoxin could be a potential therapeutic agent in the treatment of retinoblastoma by regulating the cell cycle genes via a non-canonical TGF-β signaling pathway.

c-Myc eye cancer gene expression P21 P15 real-time PCR.

References (23)

  1. 1 Mutation and Cancer: Statistical Study of Retinoblastoma [DOI]
  2. 2 Molecular and cellular endocrinology [DOI]
  3. 3 Mortality From Second Tumors Among Long-Term Survivors of Retinoblastoma [DOI]
  4. 4 Characterisation of retinoblastomas without RB1 mutations: genomic, gene expression, and clinical studies [DOI]
  5. 5 Digitoxin is a potential anticancer agent for several types of cancer [DOI]
  6. 6 Genetic and epigenetic mutations of tumor suppressive genes in sporadic pituitary adenoma [DOI]
  7. 7 Digitoxin and a synthetic monosaccharide analog inhibit cell viability in lung cancer cells [DOI]
  8. 8 The Fibrotic Phenotype Induced by IGFBP-5 Is Regulated by MAPK Activation and Egr-1-Dependent and -Independent Mechanisms [DOI]
  9. 9 Treatment of congestive heart failure - current status of use of digitoxin [DOI]
  10. 10 Digoxin inhibits neuroblastoma tumor growth in mice.
  11. 11 Retinoblastoma: diagnosis and management—the UK perspective [DOI]
  12. 12 The cardiac sodium pump: structure and function [DOI]
  13. 13 Chemosensitivity and multidrug resistance to antineoplastic drugs in retinoblastoma cell lines.
  14. 14 Digoxin use and the risk for colorectal cancer [DOI]
  15. 15 Tumour suppressor genes in prostate cancer [DOI]
  16. 16 Role of MYCN in retinoblastoma [DOI]
  17. 17 William withering revisited: 200 years of the Foxglove [DOI]
  18. 18 Mortality from Second Tumors Among Long-Term Survivors of Retinoblastoma [DOI]
  19. 19 Digitoxin; a critical review.
  20. 20 [Ophthalmic oncology: achievements over the last two decades].
  21. 21 European Journal of Clinical Investigation [DOI]
  22. 22 American journal of physiology / Cell physiology
  23. 23 Clinical & translational oncology : official publication of the Federation of Spanish Oncology Societies and of the National Cancer Institute of Mexico.

Cited by 5

Showing 2 of 5 known citations — external sources report more than can currently be individually listed.

Article metrics

Real usage data collected on this platform.

6

Page views

0

PDF downloads

0

Outbound clicks

5

Citations

Views over time

Views by country

Approximate, from request IP at view time — not citizenship or institution. Countries with fewer than 5 views are grouped as "Other".

Traffic sources

Referring site, by host.

Views and downloads exclude known bots/crawlers. Citations combines this platform's own DOI-resolved index with each external source's own reported total — see Cited by above for individually listed citing works. Last refreshed 0 seconds ago.